Clinical Trial

Drug Interaction Study on Linaprazan Glurate Capsules

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study is a drug-drug interaction (DDI) investigation involving Linaprazan Glurate capsules and a combination of clarithromycin tablets, amoxicillin capsules, and bismuth potassium citrate capsules. The study plan is divided into two parts: one involving Hp-negative healthy subjects and the other involving Hp-positive subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-08.
Status change: Recruiting → Completed 2026-01-04
Trial Details
NCT Number NCT07294846
Lead Sponsor Jiangsu Sinorda Biomedicine Co., Ltd
Conditions Healthy Volunteers, Patients
Enrollment 56 participants
Start Date 2025-09-08
Primary Completion 2025-12-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-06